Mayur Ramesh

Advances in the diagnosis and treatment of Clostridium difficile infections

Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta‐analysis

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

Features, Evaluation and Treatment Coronavirus (COVID-19)

Microbiota in health and diseases

Non-traditional Antibacterial Therapeutic Options and Challenges

Antibiotic resistance: a rundown of a global crisis

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

Antibiotic development — economic, regulatory and societal challenges

Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial Applications

Gut microbiome and health: mechanistic insights

Nation-wide measure of variability in HCMV, EBV and BKV DNA quantification among centers involved in monitoring transplanted patients

Whole genome sequencing in clinical and public health microbiology

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

Hidradenitis suppurativa

Ulcerative colitis

Gut microbiota changes in the extreme decades of human life: a focus on centenarians

The microbiota in cirrhosis and its role in hepatic decompensation

Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases—Clostridium difficile Disease and Beyond

Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads

The pros, cons, and many unknowns of probiotics

The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness

IBD in India

Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Obesity aggravates COVID‐19: An updated systematic review and meta‐analysis

Prevalence of Clostridium difficile Infection among Solid Organ Transplant Recipients: A Meta-Analysis of Published Studies

Faecal microbiota transplantation plus selected use of vancomycin for severe‐complicated Clostridium difficile infection: description of a protocol with high success rate

Safety and Durability of RBX2660 (Microbiota Suspension) for RecurrentClostridium difficileInfection: Results of the PUNCH CD Study

Multi-center prospective survey of inflammatory bowel diseases in Kerala: More than 2000 cases

Transmission of Methicillin-Resistant Staphylococcus aureus Infection Through Solid Organ Transplantation: Confirmation Via Whole Genome Sequencing

Clostridium difficile Infection in Liver Transplant Recipients: A Retrospective Study of Rates, Risk Factors and Outcomes

Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017

Intestinal Microbiota Transplantation, a Simple and Effective Treatment for Severe and Refractory Clostridium Difficile Infection

Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log₁₀/mL underestimates the diagnosis of BKV‐associated nephropathy: a single transplant center experience

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease

Predictors of fecal transplant failure